MoneyWorks4Me

Sun Pharmaceutical Industries informs about sustainability report

24 Dec 2022 Evaluate

Sun Pharmaceutical Industries has submitted the Sustainability Report of the Company for the financial year 2021-22, which we shall be releasing after sending this letter. The Sustainability Report of the Company shall also be made available on the website of its Company.

The above information is a part of company’s filings submitted to BSE.


Sun Pharma. Inds. Share Price

1900.70 -3.30 (-0.17%)
04-Sep-2026 15:02 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1900.70
Dr. Reddys Labs. 1155.90
Cipla 1378.00
Lupin 2104.55
Zydus Lifesciences 1125.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: